The annual awards show, celebrating creativity in marketing communications, has named Langland's executive creative director and Sudler & Hennessey chief creative officer to lead the jury.
UCB generic deal falls through; agency hiring could spike in 2015; teenage prescription drug abuse is on the decline.
Swiss drugmaker Novartis received an FDA nod for rare disease treatment Signifor LAR Tuesday, as orphan drug approvals reach new heights.
The driver on NASCAR and other racing circuits will help challenge consumers to improve their health habits.
Studies by Australian company Novogen are said to demonstrate, for the first time, that a drug highly effective against brain cancers has the same high potency against melanoma.
The new approach shows "The Talk" has a sequel.
Bayer consolidates OTC creative portfolio; Genentech R&D head steps down; Novartis receives approval for orphan drug.
The treatment reduces risk by half compared to widely used Zelboraf.
Court clears the way for a Nexavar generic from Natco
The drugmakers, who have an experimental cholesterol medication in the works, are asking consumers what they know about heart health.
Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.